期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 60, 期 9, 页码 5130-5134出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00264-16
关键词
-
资金
- Veterans Affairs Research and Development
- HHS \ NIH \ National Institute of Allergy and Infectious Diseases (NIAID) [R01AI100560, R01AI072219, R01AI063517]
- HHS \ NIH \ National Center for Advancing Translational Sciences (NCATS) [UL1TR000439]
Stenotrophomonas maltophilia is an emerging multidrug-resistant (MDR) opportunistic pathogen for which new antibiotic options are urgently needed. We report our clinical experience treating a 19-year-old renal transplant recipient who developed prolonged bacteremia due to metallo-beta-lactamase-producing S. maltophilia refractory to conventional treatment. The infection recurred despite a prolonged course of colistimethate sodium (colistin) but resolved with the use of a novel drug combination with clinical efficacy against the patient's S. maltophilia isolate.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据